Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.

MLA

Denburg, Avram E., et al. “Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.” JCO Global Oncology, vol. 8, June 2022, p. e2200034. EBSCOhost, https://doi.org/10.1200/GO.22.00034.

APA

Denburg, A. E., Fundytus, A., Khan, M. S., Howard, S. C., Antillon-Klussmann, F., Sengar, M., Lombe, D., Hopman, W., Jalink, M., Gyawali, B., Trapani, D., Roitberg, F., De Vries, E. G. E., Moja, L., Ilbawi, A., Sullivan, R., & Booth, C. M. (2022). Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey. JCO Global Oncology, 8, e2200034. https://doi.org/10.1200/GO.22.00034

Chicago

Denburg, Avram E, Adam Fundytus, Muhammad Saghir Khan, Scott C Howard, Federico Antillon-Klussmann, Manju Sengar, Dorothy Lombe, et al. 2022. “Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.” JCO Global Oncology 8 (June): e2200034. doi:10.1200/GO.22.00034.